Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Interest Expenses (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Interest Expenses for 4 consecutive years, with $6000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 89.29% to $6000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $90000.0, a 70.68% decrease, with the full-year FY2025 number at $90000.0, down 70.68% from a year prior.
  • Interest Expenses was $6000.0 for Q4 2025 at Spruce Biosciences, down from $19000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $131000.0 in Q1 2023 to a low of $6000.0 in Q4 2025.
  • A 4-year average of $81250.0 and a median of $90500.0 in 2022 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: skyrocketed 50.57% in 2023, then crashed 89.29% in 2025.
  • Spruce Biosciences' Interest Expenses stood at $129000.0 in 2022, then dropped by 17.83% to $106000.0 in 2023, then tumbled by 47.17% to $56000.0 in 2024, then plummeted by 89.29% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Interest Expenses are $6000.0 (Q4 2025), $19000.0 (Q3 2025), and $29000.0 (Q2 2025).